GeneDx Recognizes Cerebral Palsy Awareness Month with Commitment to Improve Access to Testing GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes ...

The ease of genetically engineering mice has led to the development of disease model strains that precisely mimic human conditions. These strains provide the ideal testbed for evaluating novel ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and ...

SOUTH SAN FRANCISCO, Calif. & ST. LOUIS--(BUSINESS WIRE)--Genome Medical, the leading telehealth provider of genetic services and genomics-based care, and Pierian, the global leader in advanced ...

Sharon Terry is President and CEO of Genetic Alliance, a leader in transforming health systems by being responsive to the real needs of people in their quest for health. Here, we talk about keeping ...

SALT LAKE CITY (KUTV) — Groundbreaking genome testing at Utah's Primary Children's Hospital is shedding light on rare and undiagnosed diseases, offering hope to families grappling with medical ...

Focus on Inborn Errors of Immunity expands access to exome and genome testing for the known 200,000+ patients in the US 1 impacted by these conditions and opens new opportunities for GeneDx and ...

Genome editing in vivo requires safe and efficient delivery of reagents to a target tissue. At the same time, delivery to non-target tissues, especially germline cells, must be assessed for potential ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based ...

A U.K. program—similar to one launched in New York last fall— will begin genome sequencing on 100,000 babies this year to figure out whether screening newborns for a wide range of conditions is ...